Tonix Pharmaceuticals Holding Corp.
TNXP
$15.52
$0.301.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.29M | 2.00M | 2.43M | 2.58M | 2.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.29M | 2.00M | 2.43M | 2.58M | 2.82M |
| Cost of Revenue | 1.37M | 3.27M | 943.00K | 1.18M | 1.56M |
| Gross Profit | 1.92M | -1.27M | 1.49M | 1.40M | 1.27M |
| SG&A Expenses | 25.70M | 16.20M | 10.10M | 15.58M | 7.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.36M | 30.29M | 18.48M | 25.06M | 18.38M |
| Operating Income | -33.07M | -28.30M | -16.05M | -22.48M | -15.55M |
| Income Before Tax | -32.01M | -28.27M | -16.83M | -22.11M | -14.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.01M | -28.27M | -16.83M | -22.11M | -14.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.01M | -28.27M | -16.83M | -22.11M | -14.21M |
| EBIT | -33.07M | -28.30M | -16.05M | -22.48M | -15.55M |
| EBITDA | -32.61M | -27.81M | -15.56M | -21.51M | -15.04M |
| EPS Basic | -3.59 | -3.86 | -2.84 | -9.77 | -22.68 |
| Normalized Basic EPS | -2.24 | -2.41 | -1.55 | -6.10 | -14.18 |
| EPS Diluted | -3.59 | -3.86 | -2.84 | -9.77 | -22.68 |
| Normalized Diluted EPS | -2.24 | -2.41 | -1.55 | -6.10 | -14.18 |
| Average Basic Shares Outstanding | 8.92M | 7.33M | 5.93M | 2.26M | 626.70K |
| Average Diluted Shares Outstanding | 8.92M | 7.33M | 5.93M | 2.26M | 626.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |